Complement-specific antibodies: designing novel anti-inflammatories.
Matis
L A
LA
Immunobiology Program, Alexion Pharmaceuticals, Inc., New Haven, Connecticut 06511, USA.
Rollins
S A
SA
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D001327:Autoimmune Diseases / Q000628:therapy; D003167:Complement Activation; D003182:Complement C5 / Q000276:immunology*; D015195:Drug Design; D006801:Humans; D007249:Inflammation / Q000209:etiology; D015202:Protein Engineering; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D003182:Complement C5; D011994:Recombinant Proteins